Primary bronchogenic carcinoma in recipients of heart transplants

Transplant International

Volumn 10, Issue 4, 1997, Pages 312-316

  Taniguchi, S ^a,b   Cooper, D K C ^a,c   Chaffin, J S ^a   Zuhdi, N ^a  

^a INTEGRIS Nazih Zuhdi Transplant Institute   (United States)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bronchogenic carcinoma, heart transplantation; Heart transplantation, bronchogenic carcinoma; Immunosuppression, bronchogenic carcinoma

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; CASE REPORT; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MALE; PRIORITY JOURNAL; RECIPIENT;

ADULT; CARCINOMA, BRONCHOGENIC; FEMALE; HEART TRANSPLANTATION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0030769465     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050062     Document Type: Article

References (18)

1. Bieber CP, Hunt SA, Schwinn DA, Jamieson SA, Reitz BA, Over PE, Shumway NE, Stinson EB (1981) Complications in long-term survivors of cardiac transplantation. Transplant Proc 13: 207-211
2. Couctil J-P, McGoldrick JP, Wallwork J, English TAH (1990) Malignant tumors after heart transplantation. J Heart Transplant 9: 622-626
3. Fleming RH, Jennison SH, Naunheim KS (1994) Primary bronchogenic carcinoma in the heart transplant recipient. Ann Thorac Surg 57: 1300-1301
4. Goldstein DJ, Williams DL, Oz MC, Weinberg AD, Rose EA, Michler RE (1995) De novo solid malignancies after cardiac transplantation. Ann Thorac Surg 60: 1783-1789
5. Jazzar A, Cooper DKC, Muchmore JS, Pribil A, Chaffin JS, Zuhdi N (1993) A successful regimen to reduce cytomegalovirus disease in heart transplant patients. Transplantology 4: 47-53
6. Jazzar A, Fagiuoli S, Sisson S, Zuhdi N, Cooper DKC (1995) Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Clin Transplantation 9: 334-339
7. Krikorian JG, Anderson JL, Bieber CP, Penn I, Stinson EB (1978) Malignant neoplasms following cardiac transplantation. JAMA 240: 639-643
8. Lanza RP, Cooper DKC, Cassidy MJD, Barnard CN (1983) Malignant neoplasms occurring after cardiac transplantation. JAMA 249: 1746-1748
9. Mountain CF (1986) A new international staging system for lung cancer. Chest 89 [Suppl]: 225S-233S
10. Penn I (1993) Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 7: 431-445
11. Penn I (1994) The problem of cancer in organ transplant recipients: an overview. Transplant Sci 4: 23-32
12. Penn I (1995) Solid tumors in cardiac allograft recipients. Ann Thorac Surg 60: 1559-1560
13. Penn I (1996) Malignant neoplasia in the immunocompromised patient. In: Cooper DKC, Miller LW, Patterson GA (eds) The transplantation and replacement of thoracic Organs, 2nd edn, Kluwer, London, pp 111-118
14. Pham SM, Kormos RL, Landreneau RJ, Kawai A, Gonzalez-Cancel I, Hardesty RL, Hattler BG, Griffith BP (1995) Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg 60: 1623-1626
15. Sheil AGR, Disney APS, Mathew TH, Amiss N (1993) De novo malignancy emerges as a major cause of morbidity and late failure In renal transplantation. Transplant Proc 25: 1383-1384
16. Weintraub J, Warnke RA (1982) Lymphoma in cardiac allotransplant recipients. Clinical and histological features and immunological phenotype. Transplantation 33: 347-351
17. Xerri L, Payan M-J, Choux R, Gros N, Hassoun J, Chamlian A, Glin D, Monties J-R (1989) An exceptional 18-year follow-up after cardiac transplantation. How can malignancies occur during immunosuppressive therapy? Cancer 63: 1697-1699
18. Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE (1991) Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 68: 2095-2100